The Case for Reactive Mass Oral Cholera Vaccinations
Author Information
Author(s): Rita Reyburn, Jacqueline L. Deen, Rebecca F. Grais, Sujit K. Bhattacharya, Dipika Sur, Anna L. Lopez, Mohamed S. Jiddawi, John D. Clemens, Lorenz von Seidlein
Primary Institution: International Vaccine Institute (IVI), Seoul, Korea
Hypothesis
Can reactive mass oral cholera vaccinations significantly reduce cholera cases during outbreaks?
Conclusion
Reactive vaccine use can prevent cholera cases and is a rational response to cholera outbreaks in both endemic and non-endemic settings.
Supporting Evidence
- 34,900 cholera cases and 1,695 deaths could have been prevented in Zimbabwe with a rapid vaccination response.
- Vaccination campaigns can significantly reduce cholera cases in both endemic and non-endemic settings.
- Even delayed vaccination responses can save a substantial number of cases and deaths.
- A single-dose vaccine would be advantageous in short outbreaks.
Takeaway
If we give cholera vaccines quickly during an outbreak, we can stop a lot of people from getting sick.
Methodology
Data from cholera outbreaks in Zimbabwe, Kolkata, and Zanzibar were analyzed to estimate preventable cases under different vaccination scenarios.
Potential Biases
Potential underreporting of cholera cases and reliance on clinical diagnoses may introduce bias.
Limitations
The study may not represent all cholera outbreaks and relied on existing data, which could be incomplete.
Participant Demographics
The study included populations from Zimbabwe, Kolkata (India), and Zanzibar (Tanzania), with varying cholera endemicity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website